JeffreyPeterWardMD

PubMed

• 6 citations
  Trends in Stage I Lung Cancer.
  Aashray Singareddy, Mary Ellen Flanagan, Pamela P Samson, Saiama N Waqar, Siddhartha Devarakonda, Jeffrey P Ward, Brett H Herzog, Anjali Rohatgi, Clifford G Robinson, ...> ;Clinical Lung Cancer. 2023 Mar 1
• 5 citations
  Ramucirumab plus atezolizumab in patients with stage IV non-small cell lung cancer previously treated with immune checkpoint inhibitors.
  Brett H Herzog, Saiama N Waqar, Siddhartha Devarakonda, Jeffrey P Ward, Feng Gao, Ramaswamy Govindan, Daniel Morgensztern> ;Lung Cancer. 2022 Nov 1
• 8 citations
  BHLHE40 Regulates the T-Cell Effector Function Required for Tumor Microenvironment Remodeling and Immune Checkpoint Therapy Efficacy.
  Avery J Salmon, Alexander S Shavkunov, Qi Miao, Nicholas N Jarjour, Sunita Keshari, Ekaterina Esaulova, Charmelle D Williams, Jeffrey P Ward, Anna M Highsmith, Josué E...> ;Cancer Immunology Research. 2022 May 3
• 2 citations
  Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung Cancer.
  Brendan Knapp, Laura Mezquita, Siddhartha Devarakonda, Mihaela Aldea, Saiama N Waqar, Kym Pepin, Jeffrey P Ward, Angela Botticella, Karen Howarth, Charlene Knape, Cliv...> ;Frontiers in Oncology. 2022 Jan 1
• 13 citations
  Phase I/Dose Expansion Trial of Brentuximab vedotin/Lenalidomide in Relapsed or Refractory Diffuse Large B-cell Lymphoma.
  Jeffrey P. Ward, Melissa M. Berrien-Elliott, Felicia Gomez, Jingqin Luo, Michelle Becker-Hapak, Amanda F. Cashen, Nina D. Wagner-Johnston, Kami J. Maddocks, Matthew Mo...> ;Blood. 2021 Nov 15
• 32 citations
  Genomic Profiling of Lung Adenocarcinoma in Never-Smokers
  Siddhartha Devarakonda, Yize Li, Fernanda Martins Rodrigues, Sumithra Sankararaman, Humam Kadara, Chandra Goparaju, Irena Lanc, Kymberlie H. Pepin, Saiama N. Waqar, Da...> ;Journal of Clinical Oncology. 2021 Sep 30
• 1 citations
  Bcl6-Independent In Vivo Development of Functional Type 1 Classical Dendritic Cells Supporting Tumor Rejection.
  Prachi Bagadia, Kevin W. O'Connor, Renee Wu, Stephen T. Ferris, Jeffrey P. Ward, Robert D. Schreiber, Theresa L. Murphy, Kenneth M. Murphy> ;Journal of Immunology. 2021 Jun 16
• 53 citations
  Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loads.
  Danielle M. Lussier, Elise Alspach, Jeffrey P. Ward, Alexander P. Miceli, Daniele Runci, J. Michael White, Cedric Mpoy, Cora D. Arthur, Heather N Kohlmiller, Tyler Jac...> ;Proceedings of the National Academy of Sciences of the United States of America. 2021 Jun 15
• 222 citations
  Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
  Daniel K. Wells, Marit M. van Buuren, Kristen K. Dang, Vanessa M. Hubbard-Lucey, Kathleen C. F. Sheehan, Katie M. Campbell, Andrew Lamb, Jeffrey P. Ward, John Sidney, ...> ;Cell. 2020 Oct 29
• 246 citations
  cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity
  Stephen T. Ferris, Vivek Durai, Renee Wu, Derek J. Theisen, Jeffrey P. Ward, Michael D. Bern, Jesse T. Davidson, Prachi Bagadia, Tiantian Liu, Carlos G. Briseño, Lijin...> ;Nature. 2020 Aug 12
• 462 citations
  MHC-II neoantigens shape tumour immunity and response to immunotherapy
  Elise Alspach, Danielle M. Lussier, Alexander P. Miceli, Ilya Kizhvatov, Michel DuPage, Adrienne M. Luoma, Wei Meng, Cheryl F. Lichti, Ekaterina Esaulova, Anthony N. V...> ;Nature. 2019 Oct 23
• 23 citations
  Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable Alterations
  Siddhartha Devarakonda, Sumithra Sankararaman, Brett H. Herzog, Kathryn A. Gold, Saiama N. Waqar, Jeffrey P. Ward, Victoria M. Raymond, Richard B. Lanman, Aadel A. Cha...> ;Clinical Cancer Research. 2019 Oct 15
• 2 citations
  Role of immune checkpoint blockers in patients with EGFR mutation.
  Jeffrey P. Ward, Daniel Morgensztern> ;Translational Lung Cancer Research. 2018 Dec 1
• 60 citations
  Erratum: High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy (Cell (2018) 175(4) (1014–...
  Matthew M. Gubin, Ekaterina Esaulova, Jeffrey P. Ward, Olga Malkova, Daniele Runci, Pamela Wong, Takuro Noguchi, Cora D. Arthur, Wei Meng, Elise Alspach, Ruan F.V. Med...> ;Cell. 2018 Nov 15
• High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy.
  Gubin, M. M.,Esaulova, E.,Ward, J. P.,Malkova, O. N.,Runci, D.,Wong, P.,Noguchi, T.,Arthur, C. D.,Meng, W.,Alspach, E.,Medrano, RFV.,Fronick, C.,Fehlings, M.,Newell, E...> ;Cell. 2018 Oct 23
• 3 citations
  Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells.
  Michael G. Fehlings, Yannick Simoni, Hweixian Leong Penny, Etienne Becht, Chiew Yee Chiew Yee Loh, Matthew M. Gubin, Jeffrey P. Ward, Siew Cheng Wong, Robert D. Schrei...> ;Nature Communications. 2018 Jul 26
• 87 citations
  Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells
  Michael G. Fehlings, Yannick Simoni, Hweixian Leong Penny, Etienne Becht, Chiew Yee Loh, Matthew M. Gubin, Jeffrey P. Ward, Siew Cheng Wong, Robert D. Schreiber, Evan ...> ;Nature Communications. 2017 Sep 15
• 202 citations
  Temporally-Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape
  Takuro Noguchi, Jeffrey P. Ward, Matthew M. Gubin, Cora D. Arthur, Sang Hun Lee, Jasreet Hundal, Mark J. Selby, Robert F. Graziano, Elaine R. Mardis, Alan J. Korman, R...> ;Cancer Immunology Research. 2017 Feb 1
• 68 citations
  Endogenous Neoantigen-specific CD8 T Cells Identified in Two Glioblastoma Models Using a Cancer Immunogenomics Approach
  Tanner M. Johanns, Jeffrey P. Ward, Christopher A. Miller, Courtney Wilson, Dale K. Kobayashi, Diane Bender, Yujie Fu, Anton Alexandrov, Elaine R. Mardis, Maxim N. Art...> ;Cancer Immunology Research. 2016 Dec 1
• 17 citations
  CD155 on HIV-Infected Cells Is Not Modulated by HIV-1 Vpu and Nef but Synergizes with NKG2D Ligands to Trigger NK Cell Lysis of Autologous Primary HIV-Infected Cells
  Zachary Davis, Bharatwaj Sowrirajan, Andrew C. Cogswell, Jeffery P. Ward, Vicente Planelles, Edward D. Barker> ;AIDS Research and Human Retroviruses. 2016 Jul 20
• 150 citations
  The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer
  Jeffrey P. Ward, Matthew M. Gubin, Robert D. Schreiber> ;Advances in Immunology. 2016 Jan 1
• 8 citations
  Understanding the molecular manipulation of DCAF1 by the lentiviral accessory proteins Vpr and Vpx
  Patrick A Cassiday, Ana Beatriz DePaula-Silva, Jeffrey Chumley, Jeffrey P. Ward, Edward D. Barker, Vicente Planelles> ;Virology. 2015 Feb 1
• 1454 citations
  Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
  Matthew M. Gubin, Xiuli Zhang, Heiko Schuster, Etienne Caron, Jeffrey P. Ward, Takuro Noguchi, Yulia Ivanova, Jasreet Hundal, Cora D. Arthur, Willem Jan Krebber, Gwenn...> ;Nature. 2014 Nov 27
• 11 citations
  Preparation and use of HIV-1 infected primary CD4+ T-cells as target cells in natural killer cell cytotoxic assays.
  Zachary Davis, Jeffrey P. Ward, Edward D. Barker> ;Journal of Visualized Experiments. 2011 Mar 14
• 144 citations
  Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu.
  Ankur H. Shah, Bharatwaj Sowrirajan, Zachary Davis, Jeffrey P. Ward, Edward M. Campbell, Vicente Planelles, Edward D. Barker> ;Cell Host & Microbe. 2010 Nov 18
• Join now to see all